This includes Fibroblast Growth Factor 23 (FGF-23), Sclerostin, Dickkopf-1, and Dickkopf-3, which have emerged as promising biomarkers for CKD-MBD. The gene discussed is FGF23; the disease is Marchiafava-Bignami disease.